Japan's Takeda plans to sell consumer health unit for around $3.7 bln - Nikkei
TOKYO, April 24 (Reuters) - Japan's Takeda Pharmaceutical Co
Ltd 4502.T plans to sell its consumer health unit for around
400 billion yen ($3.72 billion), Nikkei Business reported.
Possible buyers of the unit include Taisho Pharmaceutical
Co. 4581.T and large investment funds, Nikkei reported. A
Takeda spokeswoman said the company does not comment on rumours.
Following its acquisition of Shire Plc in 2019 for $59
billion, Takeda has pledged to dispose of $10 billion worth of
non-core assets to pare down debt.
($1 = 107.6500 yen)
(Reporting by Rocky Swift; Editing by Muralikumar Anantharaman)
((rocky.swift@thomsonreuters.com;))
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10